MRI-safe IV system maker iRadimed files for a $12 million IPO

Comment

Shutterstock photo

iRadimed, which makes non-magnetic IV systems that are safe to use during MRI procedures, filed on Wednesday with the SEC to raise up to $12 million in an initial public offering. The Winter Park, FL-based company, which was founded in 1992 and booked $12 million in sales for the 12 months ended March 31, 2014, plans to list on the NASDAQ under the symbol IRMD. Roth Capital is the sole bookrunner on the deal. No pricing terms were disclosed.

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.



This article appears in: News Headlines , IPOs


More from Renaissance Capital

Subscribe






Renaissance Capital
Contributor:

Renaissance Capital

IPOs
Follow on:

Find a Credit Card

Select a credit card product by:
Select an offer:
Search
Data Provided by BankRate.com